clinical trial · NCT06880848
Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
Jemincare·phase4·completed·n = 160
Carcinoma, Basal Cell (BCC)Sonidegib Phosphate Capsules
brief summary
This is a Phase IV, single arm, multicenter study designed to evaluate the efficacy and safety profile of Sonidegib in chinese participants with locally advanced basal cell carcinoma (laBCC) who are not amenable to radiation therapy, curative surgery or other local therapies.
started
Jun 21, 2023
primary completion
Aug 26, 2025
completion
Aug 26, 2025
last updated
Sep 24, 2025
official title
A Prospective, Open-Label, Single-Arm, Multi-Center, Phase IV Efficacy and Safety Study of Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol